Xiao Wang , Xinwei Hao , Yuqing Yang, Siyu Jia, Yating Chen, Wenguang Yang, Yi Luo, Zhen Xie, Yanchao Gu, Yuxuan Wu, Fuhua Zhang, Mengyuan Li, Yao Wang, Xihui Shen, Lei Xu
{"title":"耶尔森氏菌中的一种磷酸二酯酶 CpdB 能降解 CDNs,从而抑制先天性免疫反应","authors":"Xiao Wang , Xinwei Hao , Yuqing Yang, Siyu Jia, Yating Chen, Wenguang Yang, Yi Luo, Zhen Xie, Yanchao Gu, Yuxuan Wu, Fuhua Zhang, Mengyuan Li, Yao Wang, Xihui Shen, Lei Xu","doi":"10.1016/j.vetmic.2024.110194","DOIUrl":null,"url":null,"abstract":"<div><p><em>Yersinia pseudotuberculosis</em> (<em>Yptb</em>) is a pathogenic gram-negative bacterium that can colonize the intestines of different animals. Its infection leads to the activation of the host’s innate immunity. Both host and bacterial-derived cyclic dinucleotides (CDNs) could activate the innate immune response of host cells. In bacteria, CDNs like c-di-AMP, c-di-GMP, or 3′3'-cGAMP can be hydrolyzed by different hydrolases. Recent studies showed that the degradation of those second messengers helps the pathogen evade immune detection. In this study, we identified a hydrolase, YPK_3776, namely CpdB in <em>Yptb</em>. CpdB is predicted to bind bacterial-derived c-di-AMP, c-di-GMP, 3′3'-cGAMP and host-derived 2′3'-cGAMP. Surprisingly, by using high-performance liquid chromatography (HPLC), we found that CpdB could only degrade bacterial-derived CDNs but not host-derived 2′3'-cGAMP. In addition, CpdB has 2′3'-cNMP activity. Consistently, the <em>Yptb</em> mutant lacking the <em>cpdB</em> gene exhibited a higher level of intracellular c-di-GMP. Furthermore, the ∆<em>cpdB</em> mutant elicited stronger innate immune responses during <em>Yptb</em> infection in macrophages, suggesting CpdB enables <em>Yptb</em> to evade host immune surveillance. Furthermore, CpdB inhibited the <em>Yptb</em>-induced innate immune response in a STING-dependent manner. Finally, we showed the ∆<em>cpdB</em> infection in mice model exhibited in lower bacterial burden, as compared to wild-type strain infection, indicating CpdB is important for bacterial survival in the host. Together, we identified a cyclic dinucleotide hydrolase CpdB in <em>Yptb</em> that could degrade bacterial-derived CDNs which help the pathogen to evade immune detection via the STING pathway.</p></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"297 ","pages":"Article 110194"},"PeriodicalIF":2.4000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response\",\"authors\":\"Xiao Wang , Xinwei Hao , Yuqing Yang, Siyu Jia, Yating Chen, Wenguang Yang, Yi Luo, Zhen Xie, Yanchao Gu, Yuxuan Wu, Fuhua Zhang, Mengyuan Li, Yao Wang, Xihui Shen, Lei Xu\",\"doi\":\"10.1016/j.vetmic.2024.110194\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><em>Yersinia pseudotuberculosis</em> (<em>Yptb</em>) is a pathogenic gram-negative bacterium that can colonize the intestines of different animals. Its infection leads to the activation of the host’s innate immunity. Both host and bacterial-derived cyclic dinucleotides (CDNs) could activate the innate immune response of host cells. In bacteria, CDNs like c-di-AMP, c-di-GMP, or 3′3'-cGAMP can be hydrolyzed by different hydrolases. Recent studies showed that the degradation of those second messengers helps the pathogen evade immune detection. In this study, we identified a hydrolase, YPK_3776, namely CpdB in <em>Yptb</em>. CpdB is predicted to bind bacterial-derived c-di-AMP, c-di-GMP, 3′3'-cGAMP and host-derived 2′3'-cGAMP. Surprisingly, by using high-performance liquid chromatography (HPLC), we found that CpdB could only degrade bacterial-derived CDNs but not host-derived 2′3'-cGAMP. In addition, CpdB has 2′3'-cNMP activity. Consistently, the <em>Yptb</em> mutant lacking the <em>cpdB</em> gene exhibited a higher level of intracellular c-di-GMP. Furthermore, the ∆<em>cpdB</em> mutant elicited stronger innate immune responses during <em>Yptb</em> infection in macrophages, suggesting CpdB enables <em>Yptb</em> to evade host immune surveillance. Furthermore, CpdB inhibited the <em>Yptb</em>-induced innate immune response in a STING-dependent manner. Finally, we showed the ∆<em>cpdB</em> infection in mice model exhibited in lower bacterial burden, as compared to wild-type strain infection, indicating CpdB is important for bacterial survival in the host. Together, we identified a cyclic dinucleotide hydrolase CpdB in <em>Yptb</em> that could degrade bacterial-derived CDNs which help the pathogen to evade immune detection via the STING pathway.</p></div>\",\"PeriodicalId\":23551,\"journal\":{\"name\":\"Veterinary microbiology\",\"volume\":\"297 \",\"pages\":\"Article 110194\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary microbiology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378113524002165\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113524002165","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response
Yersinia pseudotuberculosis (Yptb) is a pathogenic gram-negative bacterium that can colonize the intestines of different animals. Its infection leads to the activation of the host’s innate immunity. Both host and bacterial-derived cyclic dinucleotides (CDNs) could activate the innate immune response of host cells. In bacteria, CDNs like c-di-AMP, c-di-GMP, or 3′3'-cGAMP can be hydrolyzed by different hydrolases. Recent studies showed that the degradation of those second messengers helps the pathogen evade immune detection. In this study, we identified a hydrolase, YPK_3776, namely CpdB in Yptb. CpdB is predicted to bind bacterial-derived c-di-AMP, c-di-GMP, 3′3'-cGAMP and host-derived 2′3'-cGAMP. Surprisingly, by using high-performance liquid chromatography (HPLC), we found that CpdB could only degrade bacterial-derived CDNs but not host-derived 2′3'-cGAMP. In addition, CpdB has 2′3'-cNMP activity. Consistently, the Yptb mutant lacking the cpdB gene exhibited a higher level of intracellular c-di-GMP. Furthermore, the ∆cpdB mutant elicited stronger innate immune responses during Yptb infection in macrophages, suggesting CpdB enables Yptb to evade host immune surveillance. Furthermore, CpdB inhibited the Yptb-induced innate immune response in a STING-dependent manner. Finally, we showed the ∆cpdB infection in mice model exhibited in lower bacterial burden, as compared to wild-type strain infection, indicating CpdB is important for bacterial survival in the host. Together, we identified a cyclic dinucleotide hydrolase CpdB in Yptb that could degrade bacterial-derived CDNs which help the pathogen to evade immune detection via the STING pathway.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.